medicalnewstoday.com
May 22, 2008
Alba Therapeutics Corporation announced that data from its Phase IIa clinical trial were presented in the Clinical Advances in Celiac Disease session at the Digestive Disease Week (DDW) meeting in San Diego, California. Results of the randomized, double- blind, placebo controlled study of...
[read full story]